chr8-116852713-TAAAAA-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 2P and 8B. PM2BS1BS2
The NM_006265.3(RAD21):c.1162-10_1162-6delTTTTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,043,840 control chromosomes in the GnomAD database, including 1 homozygotes. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000048 ( 1 hom. )
Consequence
RAD21
NM_006265.3 splice_region, intron
NM_006265.3 splice_region, intron
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.05
Publications
3 publications found
Genes affected
RAD21 (HGNC:9811): (RAD21 cohesin complex component) The protein encoded by this gene is highly similar to the gene product of Schizosaccharomyces pombe rad21, a gene involved in the repair of DNA double-strand breaks, as well as in chromatid cohesion during mitosis. This protein is a nuclear phospho-protein, which becomes hyperphosphorylated in cell cycle M phase. The highly regulated association of this protein with mitotic chromatin specifically at the centromere region suggests its role in sister chromatid cohesion in mitotic cells. [provided by RefSeq, Jul 2008]
RAD21 Gene-Disease associations (from GenCC):
- Cornelia de Lange syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Cornelia de Lange syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- Mungan syndromeInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.00000479 (5/1043840) while in subpopulation SAS AF = 0.000114 (5/43732). AF 95% confidence interval is 0.0000444. There are 1 homozygotes in GnomAdExome4. There are 2 alleles in the male GnomAdExome4 subpopulation. This position passed quality control check.
BS2
High AC in GnomAdExome4 at 5 AD,Unknown gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RAD21 | NM_006265.3 | c.1162-10_1162-6delTTTTT | splice_region_variant, intron_variant | Intron 9 of 13 | ENST00000297338.7 | NP_006256.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome AF: 0.00000479 AC: 5AN: 1043840Hom.: 1 AF XY: 0.00000390 AC XY: 2AN XY: 513310 show subpopulations
GnomAD4 exome
AF:
AC:
5
AN:
1043840
Hom.:
AF XY:
AC XY:
2
AN XY:
513310
show subpopulations
African (AFR)
AF:
AC:
0
AN:
22328
American (AMR)
AF:
AC:
0
AN:
19138
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
16880
East Asian (EAS)
AF:
AC:
0
AN:
27488
South Asian (SAS)
AF:
AC:
5
AN:
43732
European-Finnish (FIN)
AF:
AC:
0
AN:
36786
Middle Eastern (MID)
AF:
AC:
0
AN:
3932
European-Non Finnish (NFE)
AF:
AC:
0
AN:
830988
Other (OTH)
AF:
AC:
0
AN:
42568
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.